glp 1 and kidney function GLP-1 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of failure. Adverse events are mostly gastrointestinal SGLT2 vs GLP-1 for CKD:

A 12-week clinical trial showed subjects taking AOD-9604 (1 mg/d) lost an average of 2.6 kg, compared to 0.8 kg in the placebo group.

Cet antioxydant naturel contribue galement rduire les symptmes provoqus par plusieurs pathologies comme : la maladie de Parkinson, qui induit une hausse du stress oxydatif au niveau crbral : on a observ une amlioration de la fonction motrice chez les patients disposant dun traitement base de glutathion

UV radiation and, to a lesser extent, visible light accelerate the oxidation of benzyl alcohol to benzaldehyde

Functioning as a selenium shuttle, PRDX2 delivers selenide to SEPHS2 to enhance GPX4 and other selenoprotein expression, thereby antagonizing ferroptosis and creating a permissive environment for cancer development (134)

doi: 10.1038/nchembio.2238 79 RotheTGruberFUderhardtSIpseizNRossnerSOskolkovaOet al